<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005890</url>
  </required_header>
  <id_info>
    <org_study_id>NCRR-M01RR08084-0043</org_study_id>
    <secondary_id>CHMC-C-96-3-5</secondary_id>
    <nct_id>NCT00005890</nct_id>
  </id_info>
  <brief_title>Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Center for Research Resources (NCRR)</source>
  <brief_summary>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
      I. Examine adrenal cortical function and the incidence of adrenal dysfunction in children&#xD;
      with septic shock.&#xD;
&#xD;
      II. Examine the mortality, length of stay in the PICU, and incidence of multiorgan failure in&#xD;
      children with adrenal dysfunction and septic shock.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROTOCOL OUTLINE:&#xD;
&#xD;
      Patients undergo a corticotropin stimulation test within 8 hours of admission to the PICU.&#xD;
      Blood samples for plasma cortisol and corticotropin levels are drawn at time 0 followed by&#xD;
      corticotropin 1-24 IV. Additional cortisol levels are drawn at 30 and 60 minutes.&#xD;
      Corticotropin is measured by immunoradiometric assay and cortisol is measured by&#xD;
      radioimmunoassay. Mean arterial blood pressure, heart rate, and respiratory rate are recorded&#xD;
      at baseline and at 60 minutes.&#xD;
&#xD;
      Patients receive routine management for septic shock and multiple organ system failure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 1996</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Diagnostic</primary_purpose>
  </study_design_info>
  <enrollment>56</enrollment>
  <condition>Septic Shock</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>corticotropin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        PROTOCOL ENTRY CRITERIA:&#xD;
&#xD;
        --Disease Characteristics--&#xD;
&#xD;
        Patients admitted to the PICU with septic shock; Hypotension (systolic blood pressure less&#xD;
        than 2 standard deviations below age normal) plus 3 or more of the following: temperature&#xD;
        greater than 38 or less than 36 degrees Celsius; heart rate greater than 90th percentile&#xD;
        for age; respiratory rate greater than 90th percentile for age; WBC greater than 12,000/mm3&#xD;
        or less than 4,000/mm3 or greater than 10% band forms; perfusion abnormalities including&#xD;
        lactic acidosis, oliguria, or an acute alteration in mental status&#xD;
&#xD;
        Arterial or central venous catheter in place&#xD;
&#xD;
        --Prior/Concurrent Therapy--&#xD;
&#xD;
        At least one month since prior corticosteroids&#xD;
&#xD;
        --Patient Characteristics--&#xD;
&#xD;
        Renal: No nephrotic syndrome requiring glucocorticoids&#xD;
&#xD;
        Pulmonary: No asthma requiring glucocorticoids&#xD;
&#xD;
        Other: No condition requiring glucocorticoids (e.g., adrenal insufficiency); No&#xD;
        uncontrolled diabetes mellitus; No prior adrenal dysfunction (plasma cortisol concentration&#xD;
        less than 19 mcg/dL 30 and 60 minutes post corticotropin stimulation); No hypersensitivity&#xD;
        to corticotropin&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard J. Brilli</last_name>
    <role>Study Chair</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Medical Center - Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229-3039</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2003</verification_date>
  <study_first_submitted>June 2, 2000</study_first_submitted>
  <study_first_submitted_qc>June 2, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2000</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>immunologic disorders and infectious disorders</keyword>
  <keyword>rare disease</keyword>
  <keyword>sepsis</keyword>
  <keyword>septic shock</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenocorticotropic Hormone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

